LabCoP session (ASLM): Surveillance of histidine-rich protein genes deletion in Plasmodium falciparum (Pfhrp2/3)
Surveillance of histidine-rich protein genes deletion in Plasmodium falciparum (PFHRP2/3) [...]
Global Malaria Programme operational strategy 2024-2030
As WHO's technical department for malaria, the Global Malaria Programme [...]
Elimination of malaria and prevention of re-establishment in Sri Lanka
This publication describes the history of malaria in Sri Lanka, [...]
Safety of artemisinin and non-artemisinin antimalarials in the first trimester of pregnancy
Malaria in pregnancy is a significant health problem in malaria-endemic [...]
Diagnostic tests for detecting risk of Plasmodium vivax relapse
Relapsing malaria caused by Plasmodium vivax parasites poses a significant challenge to [...]
Larval source management: a supplementary measure for malaria vector control
Larval source management refers to the targeted management of mosquito [...]
Safety and Efficacy of a Monoclonal Antibody against Malaria in Mali
Dr. Peter Crompton, in collaboration with a team of researchers [...]
Malaria Ministerial Conference: “Tackling malaria in countries hardest hit by the disease”
WHO and partners convened a Malaria Ministerial Conference in Yaoundé, [...]
Declaration for accelerated malaria mortality reduction in Africa: commitment that “No one shall die from malaria”
Ministers of Health from African countries with the highest burden [...]
WHO review of malaria vaccine clinical development
WHO analyzed the pipeline of malaria vaccines that were in [...]
